questionsmedicales.fr
Lipides
Alcools gras
Hexanols
Cyclohexanols
Cyclohexanols : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Cyclohexanols
Tests de laboratoire
Cyclohexanols
Marqueurs biologiques
Cyclohexanols
Effets à long terme
Cyclohexanols
Symptômes
5
Effets neurologiques
Cyclohexanols
Intoxication chronique
Cyclohexanols
Système immunitaire
Cyclohexanols
Prévention
5
Réglementations
Cyclohexanols
Sensibilisation
Travailleurs
Produits ménagers
Cyclohexanols
Traitements
5
Irritation cutanée
Traitement
Suivi médical
Cyclohexanols
Complications
5
Complications
Cyclohexanols
Reproduction
Cyclohexanols
Réversibilité
Cyclohexanols
Facteurs de risque
5
Facteurs de risque
Travailleurs
Femmes enceintes
Facteurs de risque
Antécédents médicaux
Facteurs de risque
Conditions de travail
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cyclohexanols : Questions médicales les plus fréquentes",
"headline": "Cyclohexanols : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cyclohexanols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cyclohexanols"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hexanols",
"url": "https://questionsmedicales.fr/mesh/D000441",
"about": {
"@type": "MedicalCondition",
"name": "Hexanols",
"code": {
"@type": "MedicalCode",
"code": "D000441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Succinate de dèsvenlafaxine",
"alternateName": "Desvenlafaxine Succinate",
"url": "https://questionsmedicales.fr/mesh/D000069468",
"about": {
"@type": "MedicalCondition",
"name": "Succinate de dèsvenlafaxine",
"code": {
"@type": "MedicalCode",
"code": "D000069468",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.303"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Eucalyptol",
"alternateName": "Eucalyptol",
"url": "https://questionsmedicales.fr/mesh/D000077591",
"about": {
"@type": "MedicalCondition",
"name": "Eucalyptol",
"code": {
"@type": "MedicalCode",
"code": "D000077591",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.454"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Menthol",
"alternateName": "Menthol",
"url": "https://questionsmedicales.fr/mesh/D008610",
"about": {
"@type": "MedicalCondition",
"name": "Menthol",
"code": {
"@type": "MedicalCode",
"code": "D008610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.605"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tramadol",
"alternateName": "Tramadol",
"url": "https://questionsmedicales.fr/mesh/D014147",
"about": {
"@type": "MedicalCondition",
"name": "Tramadol",
"code": {
"@type": "MedicalCode",
"code": "D014147",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.802"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorhydrate de venlafaxine",
"alternateName": "Venlafaxine Hydrochloride",
"url": "https://questionsmedicales.fr/mesh/D000069470",
"about": {
"@type": "MedicalCondition",
"name": "Chlorhydrate de venlafaxine",
"code": {
"@type": "MedicalCode",
"code": "D000069470",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.901"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cyclohexanols",
"alternateName": "Cyclohexanols",
"code": {
"@type": "MedicalCode",
"code": "D003511",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rohan Karande",
"url": "https://questionsmedicales.fr/author/Rohan%20Karande",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Ingeborg Heuschkel",
"url": "https://questionsmedicales.fr/author/Ingeborg%20Heuschkel",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Anna Hoschek",
"url": "https://questionsmedicales.fr/author/Anna%20Hoschek",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Andreas Schmid",
"url": "https://questionsmedicales.fr/author/Andreas%20Schmid",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Bruno Bühler",
"url": "https://questionsmedicales.fr/author/Bruno%20B%C3%BChler",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Efficacy of lidocaine injection method for esophageal endoscopic submucosal dissection: single-center, double-blind, randomized controlled trial.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36266483",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-022-09716-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial.",
"datePublished": "2023-10-12",
"url": "https://questionsmedicales.fr/article/37839420",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S0140-6736(23)01572-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cracking double-blind review: Authorship attribution with deep learning.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37390072",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0287611"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trial.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37722238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2023.115458"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35918311",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41398-022-02039-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Alcools gras",
"item": "https://questionsmedicales.fr/mesh/D005233"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hexanols",
"item": "https://questionsmedicales.fr/mesh/D000441"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cyclohexanols",
"item": "https://questionsmedicales.fr/mesh/D003511"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cyclohexanols - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cyclohexanols",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cyclohexanols",
"description": "Comment diagnostiquer une intoxication aux cyclohexanols ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une exposition aux cyclohexanols ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer les effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Double-Blind+Method#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cyclohexanols",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nLes cyclohexanols provoquent-ils des irritations ?\nY a-t-il des effets neurologiques ?\nQuels sont les signes d'une intoxication chronique ?\nLes cyclohexanols affectent-ils le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Double-Blind+Method#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cyclohexanols",
"description": "Comment prévenir l'exposition aux cyclohexanols ?\nY a-t-il des réglementations sur leur utilisation ?\nQuels sont les conseils de sécurité en laboratoire ?\nComment sensibiliser les travailleurs ?\nLes cyclohexanols sont-ils dangereux à domicile ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Double-Blind+Method#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cyclohexanols",
"description": "Quel est le traitement d'une intoxication aiguë ?\nDes antidotes existent-ils pour les cyclohexanols ?\nComment traiter les irritations cutanées ?\nQuel suivi est nécessaire après une exposition ?\nLes traitements varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Double-Blind+Method#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cyclohexanols",
"description": "Quelles complications peuvent survenir après exposition ?\nLes cyclohexanols peuvent-ils causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nComment gérer les complications à long terme ?\nLes effets sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Double-Blind+Method#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cyclohexanols",
"description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il le risque d'exposition ?\nLes femmes enceintes sont-elles plus à risque ?\nLes antécédents médicaux influencent-ils le risque ?\nLes conditions de travail affectent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Double-Blind+Method#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux cyclohexanols ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les niveaux de cyclohexanols."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les concentrations de cyclohexanols."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux cyclohexanols ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des vertiges, et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de marqueurs biologiques spécifiques, mais des niveaux élevés dans le sang peuvent indiquer une exposition."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets à long terme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des évaluations cliniques et des suivis réguliers sont nécessaires pour détecter des effets chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des nausées, des vomissements, et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols provoquent-ils des irritations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des irritations cutanées et des troubles respiratoires en cas d'inhalation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des effets neurologiques tels que des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une intoxication chronique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, troubles de la mémoire et changements d'humeur."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols affectent-ils le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent qu'une exposition prolongée peut altérer la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux cyclohexanols ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et assurer une ventilation adéquate lors de l'utilisation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations sur leur utilisation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations existent pour limiter l'exposition professionnelle aux cyclohexanols."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils de sécurité en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter des gants, des lunettes de protection et travailler sous hotte pour minimiser l'exposition."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser les travailleurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations régulières sur les risques et les mesures de sécurité doivent être mises en place."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols sont-ils dangereux à domicile ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits ménagers, il faut donc lire les étiquettes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement d'une intoxication aiguë ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques, comme l'hydratation."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les cyclohexanols ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les cyclohexanols, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire après une exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical est recommandé pour surveiller les effets à long terme et les complications."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon l'âge ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier en fonction de l'âge et de l'état de santé général du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires chroniques et des effets neurologiques persistants."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut affecter la fertilité et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des interventions thérapeutiques peuvent aider à gérer les complications."
}
},
{
"@type": "Question",
"name": "Les effets sont-ils réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres peuvent persister même après l'arrêt de l'exposition."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et ceux manipulant des solvants sont les plus à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes travailleurs peuvent être moins conscients des risques, augmentant leur vulnérabilité."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition pendant la grossesse peut avoir des effets néfastes sur le fœtus."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents respiratoires ou neurologiques sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les conditions de travail affectent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions de travail non sécurisées augmentent le risque d'exposition aux cyclohexanols."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Departamento de Química Física y Química Inorgánica - IU CINQUIMA, Facultad de Ciencias, Universidad de Valladolid, E-47011 Valladolid, Spain. lesarri@qf.uva.es.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Physiology and Neuroscience, Rutgers, State University of New Jersey, Newark, NJ, USA.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Physiology and Neuroscience, Rutgers, State University of New Jersey, Newark, NJ, USA.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Affiliations :
Stoddart Institute of Molecular Science, Department of Chemistry, Zhejiang University, Hangzhou 310058, P. R. China. mingzhelee@zju.edu.cn.
Zhejiang-Israel Joint Laboratory of Self-Assembling Functional Materials, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, P. R. China.
Publications dans "Cyclohexanols" :
Intraoperative body movements are one of the causes of difficulty in performing esophageal endoscopic submucosal dissection (ESD) under conscious sedation. The use of local anesthetics as local inject...
This was a single-center, prospective, double-blind, randomized trial. Patients who underwent esophageal ESD under conscious sedation from June 2018 to May 2021 were included in this study. In the LIM...
Fifty patients were enrolled and randomized in a 1:1 ratio in two groups. The incidence of body movements was significantly lower in the LIM group (12% [3/25]) than in the control group (48% [12/25]; ...
LIM during esophageal ESD reduced body movements while decreasing the level of sedation. Therefore, LIM during esophageal ESD is an option for maintaining good sedation (UMIN000032804)....
Hand osteoarthritis is a disabling condition with few effective therapies. Hand osteoarthritis with synovitis is a common inflammatory phenotype associated with pain. We aimed to examine the efficacy ...
In this multisite, parallel-group, double-blind, randomised, placebo-controlled trial, participants (aged 40-75 years) with hand osteoarthritis (Kellgren and Lawrence grade ≥2 in at least one joint) a...
Between Nov 22, 2017, and Nov 8, 2021, of 202 participants who were assessed for eligibility, 97 (48%) were randomly assigned to receive methotrexate (n=50) or placebo (n=47). 68 (70%) of 97 participa...
Treatment of hand osteoarthritis and synovitis with 20 mg methotrexate for 6 months had a moderate but potentially clinically meaningful effect on reducing pain, providing proof of concept that methot...
National Health and Medical Research Council of Australia....
Double-blind peer review is considered a pillar of academic research because it is perceived to ensure a fair, unbiased, and fact-centered scientific discussion. Yet, experienced researchers can often...
We aim to develop fMRI neurofeedback as a treatment for obsessive compulsive disorder (OCD). In prior work, we found that providing neurofeedback of activity in the anterior prefrontal cortex (aPFC) i...
The use of low sub-perceptual doses of psychedelics ("microdosing") has gained popularity in recent years. Although anecdotal reports claim multiple benefits associated with this practice, the lack of...
Autism spectrum disorder (ASD) is a pervasive neurodevelopmental disorder with repetitive behaviour which affects interaction and communication. Sulforaphane (SFN), an isothiocyanate abundant in the s...
Geraniol is an acyclic monoterpene alcohol with well-known anti-inflammatory and antimicrobial properties which has shown eubiotic activity towards gut microbiota (GM) in patients with irritable bowel...
Fifty-six IBS patients diagnosed according to Rome III criteria were enrolled in an interventional, prospective, multicentric, randomized, double-blinded, placebo-controlled trial. In the treatment ar...
Patients treated with LAGS showed a significant reduction in their IBS symptoms severity score (IBS-SSS) compared to the placebo (195 vs. 265,...
LAGS was effective in treating overall IBS symptoms, together with an improvement in the gut microbiota profile, especially for the IBS mixed subtype....
Double-blinding subjects to the experiment's purpose is an important standard in neurofeedback studies. However, it is difficult to provide evidence that humans are entirely unaware of certain informa...
Double-blind, placebo-controlled food challenge (DBPCFC) remains the gold standard for diagnosing food allergy, despite sparse comparisons to open food challenges (OpenFCs). The objective of this retr...
This study included patients from the Allergy Centre, Odense University Hospital with a positive oral food challenge, defined as strict objective signs, with peanut during the period 2001-2022. Severi...
In total, 318 positive OpenFCs and 86 DBPCFCs were included. There was no difference in severity of symptoms nor threshold values comparing the two challenge types, neither when stratified for age gro...
Our findings do not advocate for DBPCFC being superior to OpenFC, if the latter is performed with strict objective stop criteria by trained staff....
Probiotics are considered safe and beneficial to human health. However, the safety of...